Ianko Iankov

2.0k total citations
54 papers, 1.6k citations indexed

About

Ianko Iankov is a scholar working on Epidemiology, Genetics and Infectious Diseases. According to data from OpenAlex, Ianko Iankov has authored 54 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Epidemiology, 22 papers in Genetics and 14 papers in Infectious Diseases. Recurrent topics in Ianko Iankov's work include Virus-based gene therapy research (22 papers), Virology and Viral Diseases (19 papers) and Animal Virus Infections Studies (13 papers). Ianko Iankov is often cited by papers focused on Virus-based gene therapy research (22 papers), Virology and Viral Diseases (19 papers) and Animal Virus Infections Studies (13 papers). Ianko Iankov collaborates with scholars based in United States, Bulgaria and Greece. Ianko Iankov's co-authors include Evanthia Galanis, Stephen J. Russell, Cory Allen, Mark J. Federspiel, Iana H. Haralambieva, Pavlos Msaouel, Cheyne Kurokawa, Ivan Mitov, James N. Ingle and Jann N. Sarkaria and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Ianko Iankov

52 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ianko Iankov United States 22 865 501 473 469 326 54 1.6k
Christine L. White United States 24 691 0.8× 455 0.9× 349 0.7× 722 1.5× 381 1.2× 46 1.9k
Erik S. Barton United States 19 785 0.9× 395 0.8× 681 1.4× 424 0.9× 912 2.8× 26 2.0k
Eric Bartee United States 22 623 0.7× 616 1.2× 555 1.2× 774 1.7× 194 0.6× 49 2.0k
Shane Knowles Canada 6 1.3k 1.5× 656 1.3× 448 0.9× 662 1.4× 319 1.0× 7 1.8k
Masmudur M. Rahman United States 24 721 0.8× 362 0.7× 562 1.2× 634 1.4× 252 0.8× 39 1.9k
Oliver Wildner Germany 25 1.1k 1.3× 663 1.3× 392 0.8× 1.0k 2.2× 265 0.8× 61 2.0k
Drew L. Lichtenstein United States 16 831 1.0× 263 0.5× 439 0.9× 572 1.2× 316 1.0× 23 1.3k
Bernardo A. Mainou United States 22 409 0.5× 369 0.7× 281 0.6× 393 0.8× 754 2.3× 58 1.5k
Laurent Poliquin Canada 15 707 0.8× 294 0.6× 382 0.8× 399 0.9× 229 0.7× 22 1.3k
David A. Ornelles United States 31 1.9k 2.2× 903 1.8× 341 0.7× 1.8k 3.8× 519 1.6× 72 3.0k

Countries citing papers authored by Ianko Iankov

Since Specialization
Citations

This map shows the geographic impact of Ianko Iankov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ianko Iankov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ianko Iankov more than expected).

Fields of papers citing papers by Ianko Iankov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ianko Iankov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ianko Iankov. The network helps show where Ianko Iankov may publish in the future.

Co-authorship network of co-authors of Ianko Iankov

This figure shows the co-authorship network connecting the top 25 collaborators of Ianko Iankov. A scholar is included among the top collaborators of Ianko Iankov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ianko Iankov. Ianko Iankov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iankov, Ianko, et al.. (2023). Personalizing Oncolytic Immunovirotherapy Approaches. Molecular Diagnosis & Therapy. 28(2). 153–168. 3 indexed citations
2.
Viker, Kimberly, Ianko Iankov, Arun Ammayappan, et al.. (2022). Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an H. pylori immunostimulatory bacterial transgene. Molecular Therapy — Methods & Clinical Development. 26. 532–546. 13 indexed citations
3.
Iankov, Ianko, Kimberly Viker, Coleman Turgeon, Dietrich Matern, & Evanthia Galanis. (2021). Parameters of immunoglobulin extraction from dried blood spot cards and immunoassays for detection of antibody response to pathogens including the novel SARS-CoV-2. Journal of Immunological Methods. 492. 112996–112996. 2 indexed citations
4.
Iankov, Ianko, Cheyne Kurokawa, Antonino B. D’Assoro, et al.. (2015). Inhibition of the Aurora A kinase augments the anti-tumor efficacy of oncolytic measles virotherapy. Cancer Gene Therapy. 22(9). 438–444. 18 indexed citations
5.
Mateo, Mathieu, Chanakha K. Navaratnarajah, Ianko Iankov, et al.. (2014). Different Roles of the Three Loops Forming the Adhesive Interface of Nectin-4 in Measles Virus Binding and Cell Entry, Nectin-4 Homodimerization, and Heterodimerization with Nectin-1. Journal of Virology. 88(24). 14161–14171. 20 indexed citations
6.
D’Assoro, Antonino B., Cosima Quatraro, Angela Amato, et al.. (2013). The mitotic kinase Aurora-A promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERα+ breast cancer cells. Oncogene. 33(5). 599–610. 101 indexed citations
7.
Iankov, Ianko, Mark J. Federspiel, & Evanthia Galanis. (2013). Measles virus expressed Helicobacter pylori neutrophil-activating protein significantly enhances the immunogenicity of poor immunogens. Vaccine. 31(42). 4795–4801. 15 indexed citations
8.
Iankov, Ianko, Cory Allen, Mark J. Federspiel, et al.. (2012). Expression of Immunomodulatory Neutrophil-activating Protein of Helicobacter pylori Enhances the Antitumor Activity of Oncolytic Measles Virus. Molecular Therapy. 20(6). 1139–1147. 52 indexed citations
9.
Iankov, Ianko, Alan R. Penheiter, Stephanie K. Carlson, & Evanthia Galanis. (2012). Development of monoclonal antibody-based immunoassays for detection of Helicobacter pylori neutrophil-activating protein. Journal of Immunological Methods. 384(1-2). 1–9. 14 indexed citations
10.
Msaouel, Pavlos, Ianko Iankov, Angela Dispenzieri, & Evanthia Galanis. (2012). Attenuated Oncolytic Measles Virus Strains as Cancer Therapeutics. Current Pharmaceutical Biotechnology. 13(9). 1732–1741. 50 indexed citations
11.
Msaouel, Pavlos, Ianko Iankov, Cory Allen, Stephen J. Russell, & Evanthia Galanis. (2011). Oncolytic Measles Virus Retargeting by Ligand Display. Methods in molecular biology. 797. 141–162. 16 indexed citations
12.
Tong, Caili, Jin Zhang, Takafumi Nakamura, et al.. (2009). Tumor and Vascular Targeting of a Novel Oncolytic Measles Virus Retargeted against the Urokinase Receptor. Cancer Research. 69(4). 1459–1468. 60 indexed citations
13.
Msaouel, Pavlos, Ianko Iankov, Cory Allen, et al.. (2009). Noninvasive Imaging and Radiovirotherapy of Prostate Cancer Using an Oncolytic Measles Virus Expressing the Sodium Iodide Symporter. Molecular Therapy. 17(12). 2041–2048. 68 indexed citations
14.
Iankov, Ianko, Pavlos Msaouel, Cory Allen, et al.. (2009). Demonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer model. Breast Cancer Research and Treatment. 122(3). 745–754. 70 indexed citations
15.
Msaouel, Pavlos, Ianko Iankov, Cory Allen, et al.. (2008). Engineered measles virus as a novel oncolytic therapy against prostate cancer. The Prostate. 69(1). 82–91. 81 indexed citations
16.
Gergova, Raina, Ianko Iankov, Iana H. Haralambieva, & Ivan Mitov. (2007). Bactericidal Monoclonal Antibody Against Moraxella catarrhalis Lipooligosaccharide Cross-Reacts with Haemophilus Spp.. Current Microbiology. 54(2). 85–90. 15 indexed citations
17.
Mitov, Ivan, et al.. (2003). Monoclonal antibody against O:5Salmonellaantigen cross-reacts with unidentified lipopolysaccharide epitope ofSalmonellaserogroup O:8 (C2âC3). FEMS Microbiology Letters. 225(2). 299–304. 6 indexed citations
18.
Mitov, Ivan, et al.. (2003). Cross-reactive monoclonal antibodies raised against the lipopolysaccharide antigen of salmonella minnesota re chemotype: diagnostic relevance. Diagnostic Microbiology and Infectious Disease. 45(4). 225–231. 12 indexed citations
19.
Haralambieva, Iana H., et al.. (2002). Characterisation of 20-kDa lectin-spermagglutinin fromArum maculatumthat preventsChlamydia pneumoniaeinfection of L-929 fibroblast cells. FEMS Immunology & Medical Microbiology. 32(3). 249–254. 2 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine L. White Breakdown of academic impact, for papers by Erik S. Barton Breakdown of academic impact, for papers by Eric Bartee Breakdown of academic impact, for papers by Shane Knowles Breakdown of academic impact, for papers by Masmudur M. Rahman Breakdown of academic impact, for papers by Oliver Wildner Breakdown of academic impact, for papers by Drew L. Lichtenstein Breakdown of academic impact, for papers by Bernardo A. Mainou Breakdown of academic impact, for papers by Laurent Poliquin Breakdown of academic impact, for papers by David A. Ornelles
Rankless by CCL
2026